This site and event is intended for UK healthcare professionals

Managing dyslipidaemia and diabetes

19 Nov 2024
Clinical Auditorium 1
Diabetes

Dyslipidaemia, characterised by abnormal cholesterol and triglyceride levels, often coexists with diabetes and plays a crucial role in exacerbating cardiovascular disease (CVD) risk in individuals living with diabetes.

Managing both dyslipidaemia and diabetes in a holistic manner is critical to reducing CVD risk and enhancing patient outcomes and involves a multifaceted approach encompassing both lifestyle and pharmacological interventions.

This session will explore the key recommendations of the ESC 2019 dyslipidaemias guidelines and NICE (NG238) CVD guidelines to help assess and reduce risks in your patients living with diabetes.

The session will also cover guidance for lipid modification with pharmacological agents. As the pharmacological arsenal available to primary care has moved far beyond statins and we explore the agents now at our disposal. We will help to demystify these agents and simplify their use in practical terms to help you achieve the cholesterol targets to best manage CVD risk.

Chairperson
Kevin Fernando
Kevin Fernando
Speakers
Niraj Lakhani
Niraj Lakhani

Our speakers 2024

Our partners, sponsors and exhibitors 2024

Guidelines Live is an educational event made possible by sponsorship from organisations including pharmaceutical companies. Sponsors have had no input into the agenda of the meeting unless through sponsored session(s) as indicated on the main programme. A list of all sponsors can be found here.


 

Quick links